Cancer drug resistance: Old concept, novel solutions required

被引：3
作者：
Peeper, Daniel S. [1 ]
机构：
[1] Netherlands Canc Inst, Div Mol Oncol, Amsterdam, Netherlands
来源：
MOLECULAR ONCOLOGY | 2014年 / 8卷 / 06期
关键词：
D O I：
10.1016/j.molonc.2014.07.026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1064 / 1066
页数：3
相关论文
共 8 条
[1]   Reading between the lines; understanding drug response in the post genomic era [J].
Alifrangis, Constantine C. ;
McDermott, Ultan .
MOLECULAR ONCOLOGY, 2014, 8 (06) :1112-1119
[2]   Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what? [J].
Borst, Piet .
OPEN BIOLOGY, 2012, 2
[3]   Tumour heterogeneity and the evolution of polyclonal drug resistance [J].
Burrell, Rebecca A. ;
Swanton, Charles .
MOLECULAR ONCOLOGY, 2014, 8 (06) :1095-1111
[4]   No longer an untreatable disease: How targeted and immunotherapies have changed the management of melanoma patients [J].
Girotti, Maria Romina ;
Saturno, Grazia ;
Lorigan, Paul ;
Marais, Richard .
MOLECULAR ONCOLOGY, 2014, 8 (06) :1140-1158
[5]   Drug resistance to targeted therapies: Deja vu all over again [J].
Groenendijk, Floris H. ;
Bernards, Rene .
MOLECULAR ONCOLOGY, 2014, 8 (06) :1067-1083
[6]   Acquired and intrinsic resistance in cancer immunotherapy [J].
Kelderman, Sander ;
Schumacher, Ton N. M. ;
Haanen, John B. A. G. .
MOLECULAR ONCOLOGY, 2014, 8 (06) :1132-1139
[7]   Brain metastasis: New opportunities to tackle therapeutic resistance [J].
Seoane, Joan ;
De Mattos-Arruda, Leticia .
MOLECULAR ONCOLOGY, 2014, 8 (06) :1120-1131
[8]   Acquired resistance to EGFR-targeted therapies in colorectal cancer [J].
Van Emburgh, Beth O. ;
Sartore-Bianchi, Andrea ;
Di Nicolantonio, Federica ;
Siena, Salvatore ;
Bardelli, Alberto .
MOLECULAR ONCOLOGY, 2014, 8 (06) :1084-1094
1